Cita APA (7a ed.)
Lv, M. (2023, February 17). MYL5 as a Novel Prognostic Marker is Associated with Immune Infiltrating in Breast Cancer: A Preliminary Study. Breast Journal, 1-22.
Cita Chicago Style (17a ed.)
Lv, Minghe. "MYL5 as a Novel Prognostic Marker Is Associated with Immune Infiltrating in Breast Cancer: A Preliminary Study." Breast Journal 17 Feb. 2023: 1-22.
Cita MLA (9a ed.)
Lv, Minghe. "MYL5 as a Novel Prognostic Marker Is Associated with Immune Infiltrating in Breast Cancer: A Preliminary Study." Breast Journal, 17 Feb. 2023, pp. 1-22.
Precaución: Estas citas no son 100% exactas.